Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Prepaid Assets: 2010-2024

Historic Prepaid Assets for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $5.5 million.

  • Anika Therapeutics' Prepaid Assets fell 10.83% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 10.83%. This contributed to the annual value of $5.5 million for FY2024, which is 26.51% down from last year.
  • As of FY2024, Anika Therapeutics' Prepaid Assets stood at $5.5 million, which was down 26.51% from $7.5 million recorded in FY2023.
  • Over the past 5 years, Anika Therapeutics' Prepaid Assets peaked at $8.8 million during FY2022, and registered a low of $5.5 million during FY2024.
  • Over the past 3 years, Anika Therapeutics' median Prepaid Assets value was $7.5 million (recorded in 2023), while the average stood at $7.3 million.
  • As far as peak fluctuations go, Anika Therapeutics' Prepaid Assets soared by 104.10% in 2020, and later decreased by 26.51% in 2024.
  • Anika Therapeutics' Prepaid Assets (MRY) stood at $8.8 million in 2020, then decreased by 5.31% to $8.3 million in 2021, then increased by 6.50% to $8.8 million in 2022, then fell by 15.31% to $7.5 million in 2023, then decreased by 26.51% to $5.5 million in 2024.
  • Its Prepaid Assets was $5.5 million in FY2024, compared to $7.5 million in FY2023 and $8.8 million in FY2022.